Camptothecin derivatives with a disulfide moiety and a piperazine moiety

This invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof (wherein X, Y, Z and n are defined herein). These compounds are useful in the treatment of diseases mediated by topoisomerase I enzyme such as cancers. The present invention also provides processes for the...

Full description

Saved in:
Bibliographic Details
Main Authors PATEL, Jiten Ranchhodbhai, SENGUPTA, Prabal, GORE, Omkar Prakash, PATEL, Gopalkumar Chimanlal, CHITTURI, Trinadha Rao
Format Patent
LanguageEnglish
Published 03.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof (wherein X, Y, Z and n are defined herein). These compounds are useful in the treatment of diseases mediated by topoisomerase I enzyme such as cancers. The present invention also provides processes for the preparation of compounds of Formula I. The compounds of the present invention are more water soluble, stable in buffer solution at various pH, and exhibit better anti-tumor activity and rapid release of SN-38 in tumor microenvironments.
AbstractList This invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof (wherein X, Y, Z and n are defined herein). These compounds are useful in the treatment of diseases mediated by topoisomerase I enzyme such as cancers. The present invention also provides processes for the preparation of compounds of Formula I. The compounds of the present invention are more water soluble, stable in buffer solution at various pH, and exhibit better anti-tumor activity and rapid release of SN-38 in tumor microenvironments.
Author CHITTURI, Trinadha Rao
PATEL, Jiten Ranchhodbhai
PATEL, Gopalkumar Chimanlal
GORE, Omkar Prakash
SENGUPTA, Prabal
Author_xml – fullname: PATEL, Jiten Ranchhodbhai
– fullname: SENGUPTA, Prabal
– fullname: GORE, Omkar Prakash
– fullname: PATEL, Gopalkumar Chimanlal
– fullname: CHITTURI, Trinadha Rao
BookMark eNrjYmDJy89L5WTwcE7MLSjJL8lITc7MU0hJLcosSyzJLEstVijPLMlQSFRIySwuzUnLTElVyM3PTC2pVEjMSwEKF2QWpBYlVmXmwcR5GFjTEnOKU3mhNDeDsptriLOHbmpBfnxqcUFicmpeakm8Y6iRgZGBsYGlkYmJo6ExcaoAyrc3JQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2020309244A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2020309244A13
IEDL.DBID EVB
IngestDate Fri Jul 26 04:26:57 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2020309244A13
Notes Application Number: AU20200309244
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&CC=AU&NR=2020309244A1
ParticipantIDs epo_espacenet_AU2020309244A1
PublicationCentury 2000
PublicationDate 20220303
PublicationDateYYYYMMDD 2022-03-03
PublicationDate_xml – month: 03
  year: 2022
  text: 20220303
  day: 03
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies SUN PHARMA ADVANCED RESEARCH COMPANY LTD
RelatedCompanies_xml – name: SUN PHARMA ADVANCED RESEARCH COMPANY LTD
Score 3.374497
Snippet This invention provides a compound of Formula I or a pharmaceutically acceptable salt thereof (wherein X, Y, Z and n are defined herein). These compounds are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Camptothecin derivatives with a disulfide moiety and a piperazine moiety
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220303&DB=EPODOC&locale=&CC=AU&NR=2020309244A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt6Jr0i59GLL1gyLsA9lkb6PpBxRmW9ZO_30vodM97S3cQUiOu1wud_cLwDOnzIqS2NQNU3Cd9YTQBWNUN1Lb4MJOOFcd3uOJFSzY-9JctmC964VROKE_ChwRLSpCe6_VeV3-P2K5qrayehEZkoo3fz5wtSY6NgzUWaq5o4E3m7pTR3McjCS1yYfkyWQCOrMhxkpH8iItkfa9z5HsSyn3nYp_DscznC-vL6CV5B04dXZ_r3XgZNykvHHYWF91CYFMFNSyZQpZJEbd-Vaw3RWRr6kkJHFWbdcpbot8FbIWk4R5jOQyK5ONgpFu6Ffw5HtzJ9BxSas_CayGi_3102to50We3ADBYCzmVipoL0Y3w8wwtSy7Lz-97EdR75XfQvfQTHeH2fdwJmWqSq5oF9r1Zps8oA-uxaMS3S8HJ4nc
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb0X7uexhyNauVF27IZ3sbTT9gMLsytrpv-8ldLqnvYU7CMlxl8vl7n4BeKSabkZJbMiqwaisK4zJTNc1WU17KmW9hFLR4e35pjvT3-bGvAHLbS-MwAn9EeCIaFER2nslzuvi_xHLFrWV5RPLkLR6cYK-LdXRsaqizmqSPeyPphN7YkmWhZGk5H9wHk8moDMbYKx00OX4vPzy9DnkfSnFrlNxTuBwivPl1Sk0krwNLWv791objrw65Y3D2vrKM3B5oqDiLVPIIjHqzreA7S4Jf00lIYmzcrNMcVvka8VrMUmYx0gusiJZCxjpmn4OD84osFwZl7T4k8BiMNtdv3YBzXyVJ5dAMBiLqZkyTYnRzehGmJpmr8s_vexGkfJMr6Czb6br_ex7aLmBN16MX_33Gzjm8hXlV1oHmtV6k9yiP67YnRDjL6LHjMk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Camptothecin+derivatives+with+a+disulfide+moiety+and+a+piperazine+moiety&rft.inventor=PATEL%2C+Jiten+Ranchhodbhai&rft.inventor=SENGUPTA%2C+Prabal&rft.inventor=GORE%2C+Omkar+Prakash&rft.inventor=PATEL%2C+Gopalkumar+Chimanlal&rft.inventor=CHITTURI%2C+Trinadha+Rao&rft.date=2022-03-03&rft.externalDBID=A1&rft.externalDocID=AU2020309244A1